Answers are grounded in this paper and cite their sources.
Demonstrates improved aspirin bioavailability through nanocrystal formulation, highlighting its pharmaceutical potential.
Aspirin’s oral bioavailability is about 50%, but this can be significantly improved through nanocrystal formulation and polymorphic transformation. However, achieving homogeneous nanocrystals with optimal stability and morphology remains challenging.
No takes yet. Share an insight, caveat, or question.
Garumanna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: